These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A review of equid herpesvirus 1 for the veterinary practitioner. Part A: clinical presentation, diagnosis and treatment. Dunowska M N Z Vet J; 2014 Jul; 62(4):171-8. PubMed ID: 24597778 [TBL] [Abstract][Full Text] [Related]
4. [Not Available]. Weitere Informationen bei: Albrecht GmbH – ein Unternehmen der Dechra Veterinary Products, 88323 Aulendorf, Tel.: (0 75 25) 205-0, E-Mail: info@dechra.com, www.dechra.de Tierarztl Prax Ausg G Grosstiere Nutztiere; 2018 Feb; 46(1):65. PubMed ID: 29571207 [No Abstract] [Full Text] [Related]
5. Cellular and antibody responses to equine herpesviruses 1 and 4. Studdert MJ J Am Vet Med Assoc; 1995 Sep; 207(6):698-701. PubMed ID: 7657564 [No Abstract] [Full Text] [Related]
6. Equine herpesvirus-1: dealing practically but effectively with an ever present threat. Gonzalez-Medina S; Newton JR Equine Vet J; 2015 Mar; 47(2):142-4. PubMed ID: 25644768 [No Abstract] [Full Text] [Related]
7. Equine herpesviruses type 1 (EHV-1) and 4 (EHV-4)--masters of co-evolution and a constant threat to equids and beyond. Ma G; Azab W; Osterrieder N Vet Microbiol; 2013 Nov; 167(1-2):123-34. PubMed ID: 23890672 [TBL] [Abstract][Full Text] [Related]
8. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus. Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488 [TBL] [Abstract][Full Text] [Related]
9. Immune escape of equine herpesvirus 1 and other herpesviruses of veterinary importance. van der Meulen KM; Favoreel HW; Pensaert MB; Nauwynck HJ Vet Immunol Immunopathol; 2006 May; 111(1-2):31-40. PubMed ID: 16472872 [TBL] [Abstract][Full Text] [Related]
10. Equine rhinopneumonitis vaccine: immunogenicity and safety in foals. Purdy CW; Porter RC; Ford SJ Am J Vet Res; 1978 May; 39(5):745-52. PubMed ID: 215062 [No Abstract] [Full Text] [Related]
11. Proceedings of the Equine Herpesvirus-1 Havermeyer Workshop. San Gimignano, Tuscany. June 2004. Vet Immunol Immunopathol; 2006 May; 111(1-2):1-125. PubMed ID: 16481044 [No Abstract] [Full Text] [Related]
12. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals. Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474 [TBL] [Abstract][Full Text] [Related]
13. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus). Fitzpatrick DR; Studdert MJ Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822 [TBL] [Abstract][Full Text] [Related]
14. Letter: Efficacy of modified live-virus equine rhinopneumonitis vaccine. Stear RL; Bass EP; Beckenhauer WH Am J Vet Res; 1976 Mar; 37(3):349-51. PubMed ID: 176909 [No Abstract] [Full Text] [Related]
15. Equine herpesvirus neurologic disease: reflections from across the pond. Kydd JH; Smith KC J Vet Intern Med; 2006; 20(3):467-8. PubMed ID: 16734076 [No Abstract] [Full Text] [Related]
16. Equine herpesvirus myeloencephalopathy: unravelling the enigma. Nugent J; Paillot R Vet J; 2009 Jun; 180(3):271-2. PubMed ID: 19141371 [No Abstract] [Full Text] [Related]
17. The equine immune response to equine herpesvirus-1: the virus and its vaccines. Kydd JH; Townsend HG; Hannant D Vet Immunol Immunopathol; 2006 May; 111(1-2):15-30. PubMed ID: 16476492 [TBL] [Abstract][Full Text] [Related]
18. Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections. Allen GP; Bryans JT Prog Vet Microbiol Immunol; 1986; 2():78-144. PubMed ID: 2856183 [No Abstract] [Full Text] [Related]
19. Report of the equine herpesvirus-1 Havermeyer Workshop, San Gimignano, Tuscany, June 2004. Slater JD; Lunn DP; Horohov DW; Antczak DF; Babiuk L; Breathnach C; Chang YW; Davis-Poynter N; Edington N; Ellis S; Foote C; Goehring L; Kohn CW; Kydd J; Matsumura T; Minke J; Morley P; Mumford J; Neubauer T; O'Callaghan D; Osterrieder K; Reed S; Smith K; Townsend H; van der Meulen K; Whalley M; Wilson WD Vet Immunol Immunopathol; 2006 May; 111(1-2):3-13. PubMed ID: 16542736 [TBL] [Abstract][Full Text] [Related]
20. [Vaccination against the paralytic form of EHV1?]. Breukink HJ; Binkhorst GJ; van Oirschot JT Tijdschr Diergeneeskd; 1983 May; 108(9):359. PubMed ID: 6306862 [No Abstract] [Full Text] [Related] [Next] [New Search]